Analysis

Novo Nordisk Takes On Hims Over Copycat GLP-1 Pill

By Yeji Jesse Lee · February 10, 2026, 6:25 PM EST

When telehealth company Hims & Hers said last week it planned to sell a GLP-1 pill dupe for the low price of $49, it caught a lot of people — including...

To view the full article, register now.

Case Information

Case Title

Novo Nordisk A/S et al v. Hims & Hers Health, Inc. et al

Case Number

1:26-cv-00143

Court

Delaware

Nature of Suit

Patent

Date Filed

February 09, 2026